Showing 421 - 425 of 425
This paper analyses the widespread difference in COVID-19 vaccination and Non-Pharmaceutical interventions (NPI) acceptance by the European population and finds that this difference can be clustered in nine archetype clusters. Calibrating a SIR model with control acceptance on COVID-19...
Persistent link: https://www.econbiz.de/10013241468
We estimate a reduced form of employment at the COVID time through a simple labor market equilibrium that accounts for workers possibly fearing work on-site (FOG) and for firms’ strategies such as work from home (WFH). Employment estimates on the French market demonstrate that work allocation...
Persistent link: https://www.econbiz.de/10013241541
This paper aims to assess the effect of competition on firm-level innovation. The sample comprises the world's top corporate R&D spenders over the period 2007 to 2016. We use an industry-year indicator, the inverse of the Lerner Index, to measure the competition level. R&D expenditures are used...
Persistent link: https://www.econbiz.de/10014256919
Despite promising announcements on an effective vaccine, the control of the COVID-19 pandemic is critically dependent on the maximal compliance of citizens to a set of non-pharmaceutical interventions (NPI for short). We use statistical clustering to partition European citizens with regards to...
Persistent link: https://www.econbiz.de/10013252190
This paper aims at assessing the relationship between the possible existence of financial constraints and the decisions of Belgian private firms as regards their investments in both capital and R&D investments over the last decade. The main system GMM estimates from the error-correction...
Persistent link: https://www.econbiz.de/10013137059